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Abstract
Background/aims—Health-related quality of life (HRQoL) measures are used in healthcare to
help inform clinical decision-making and policy-making decisions. A number of disease-specific
or condition-specific measures have been developed and applied in ophthalmology; however, their
use in the specific fields of amblyopia and strabismus are not as established. The purpose of this
study is to identify and discuss specific HRQoL instruments that may be used in the investigation
and management of patients with amblyopia and/or strabismus.
Methods—A systematic literature review was undertaken in November 2009. The electronic
databases of AMED (Allied and Complementary Medicine: 1985 to November 2009), the British
Nursing Index and Archive (1985 to October 2009), Ovid Medline In-Process and Other Non-
Indexed Citations and Ovid Medline (1950 to present) and PsycINFO (1806 to November Week 1
2009) were searched. No language restrictions were applied to the search.
Results—Four instruments were identified: the Amblyopia and Strabismus Questionnaire
(A&SQ), the Amblyopia Treatment Index (ATI), the Adult Strabismus Questionnaire (AS-20) and
the Intermittent Exotropia Questionnaire (IXTQ).
Conclusion—The use of HRQoL measures in patients with amblyopia and/or strabismus is a
developing area. Further research is necessary to determine the impact of issues such as diplopia
and poor cosmesis upon patient groups, and to determine the influence of ethnicity and parental
reporting in these patients.
INTRODUCTION
Health-related quality of life (HRQoL) measures are increasingly used in healthcare. Such
measures help to inform clinical decision-making through evidence-based practice, and can
also be used in economic evaluations to help to inform policy-making decisions. HRQoL is
a concept that incorporates physical and functional status, emotional status and social
functioning,1 and may be assessed using generic or disease or condition-specific
instruments. When considering the application of HRQoL instruments within
ophthalmology, there are concerns that generic measures are not sensitive to the recognised
symptoms of vision loss or emotional aspects of a given ophthalmic condition, such as
strabismus.
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A number of validated disease-specific or condition-specific instruments have been
developed and applied in ophthalmology, both in research and clinical practice. These
include the Visual Function Index (VF-14), the National Eye Institute Visual Function
Questionnaire2-4 (NEI-VFQ: 51- and 25-item questionnaires), the Impact of Visual
Impairment5 (IVI) and the Activities of Daily Vision Scale6 (ADVS), to name a few. Such
instruments have been used to describe the impact of a condition within a given population,
as a measure to determine the success or suitability of treatment interventions, and to assess
the impact of vision loss. The use of patient-reported outcome measures within the specific
field of amblyopia and/or strabismus is not as well established. The purpose of this study is
to identify and discuss HRQoL instruments that may be used in the investigation and
management of patients with amblyopia and/or strabismus.
METHODS
A systematic literature review was undertaken during November 2009. A specific search
strategy was employed to identify HRQoL instruments that might be used in the
investigation and management of patients with amblyopia and/or strabismus. The electronic
databases of AMED (Allied and Complementary Medicine: 1985 to November 2009), the
British Nursing Index and Archive (1985 to October 2009), Ovid Medline In-Process and
Other Non-Indexed Citations and Ovid Medline (1950 to present) and PsycINFO (1806 to
November Week 1 2009) were searched. Details of the search strategy (ie, keywords used)
are shown in box 1. No language restrictions were applied to the search.
Following removal of duplicates, 39 articles were applicable for this review. Articles were
rejected at title if they were not related to the subject area (n=4), rejected at abstract if a
vision-specific or disease-specific instrument was not used in the study (n=8), and rejected
at full paper if the study subjects could not be described as ‘orthoptic patients’—that is, did
not include subjects with a diagnosis of amblyopia and/or strabismus (n=21). These included
assessment of HRQoL in patients with sensory impairment, age-related macular
degeneration, low vision, cataract, diabetic retinopathy, choroidal melanoma and glaucoma.
This left 11 papers identified through the outlined search strategy subject to full review.
These papers described the development or administration of four HRQoL measures: the
Amblyopia and Strabismus Questionnaire (A&SQ)7-10, the Amblyopia Treatment Index
(ATI)11-13, the Adult Strabismus Quality of Life Questionnaire (AS-20)14 15 and the
Intermittent Exotropia Questionnaire (IXTQ).16 17 Additional literature was identified
through a clinical expert (n=3) and through references of the papers identified through the
electronic search (n=2). The Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA)18 flow diagram of study identification is shown in figure 1. This
additional searching was undertaken in order to identify any further papers that reported the
psychometric properties of the instruments identified from the initial literature search.
Instruments were assessed in terms of reliability, validity and responsiveness (see table 1). It
is possible to have a reliable measure that is not valid; however, a valid measure must also
be reliable. Explanations of reliability, validity and responsiveness are shown in table 1. For
the purpose of this paper, construct validity will be determined if compared with objective
clinical measures such as visual acuity or binocularity; concurrent validity will be a
comparison to an existing vision-specific HRQoL measure.
Box 1
Search strategy employed
1. Orthoptic
2. Strabismus
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3. Amblyopia
4. Visual acuity
5. Vision
6. Loss
7. Impairment
8. 5 and 6
9. 5 and 7
10. 1 or 2 or 3 or 7 or 8 or 9
11. Questionnaire
12. Quality of life
13. Cosme*
14. 11 or 12 or 13
15. 10 and 14
*denotes unlimited truncation retrieves all possible suffix variations of the root word
indicated.
RESULTS
The literature search identified four disease-specific instruments that can used in the
investigation and management of orthoptic patients: the Amblyopia and Strabismus
Questionnaire (A&SQ), the Amblyopia Treatment Index (ATI), the Adult Strabismus
Questionnaire (AS-20) and the Intermittent Exotropia Questionnaire (IXTQ). Summary
details of the instruments are shown in tables 2 and 3.
The instruments identified all used factor analysis in their development. Factor analysis is a
technique that can reduce the number of items (ie, questions) within an instrument, by
identifying redundant items. It may also be used to assess the structure of a domain (ie,
subgroup or theme, such as ‘cosmesis’ or ‘ability’) by grouping items together that are
related to each other. Factor analysis can be thought of as a confirmatory tool to assess the
structure of a developed instrument or measure.
Each instrument was shown to be reliable (in that internal consistency data was reported; see
table 1 for details); however, no test–retest data was reported for any instrument. Test–retest
data would add to the evidence of reliability for the instrument. Each instrument was also
deemed to be valid; however, only the A&SQ and AS-20 were tested against another
recognised HRQoL measure (the NEI-VFQ-25).
The A&SQ
The A&SQ was designed to assess the ‘decrease in quality of life’ of patients with
amblyopia and strabismus.7 The instrument was designed by clinicians who listed problems
that amblyopic and strabismic patients experience. These were categorised into five
domains. All items in the questionnaire are measured on Likert-type rating scales, which are
assumed to be linear and run from 0 to 100 (0 corresponding to the least favourable score
and 100 corresponding to the most favourable score). The total A&SQ score is defined as
the mean of all item scores.
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The reliability of the A&SQ has been reported in terms of internal consistency.7 Validity has
been reported in terms of discriminatory validity,7 concurrent validity7 and construct
validity9 10 (see table 1). An English-language version has also been developed and has
shown to be both reliable and valid.8
The ATI
The ATI was developed following consultation with specialists and parents of children with
amblyopia. A list of 20 items was created and the initial questionnaire was issued to parents
of children participating in the Amblyopia Treatment Study (a multi-centre randomised
controlled clinical trial designed to compare atropine and conventional patching treatment).
Slight modifications/rewording of some of the questions were made depending upon
whether the child was undertaking conventional patching treatment or atropine therapy for
the management of their amblyopia. The ATI now consists of 18-items, scored on a 5-part
Likert-type scale. The overall ATI score is the mean of all the item scores. The reliability of
the ATI has been reported in terms of internal consistency.11-13 The validity of the ATI has
been reported in terms of construct validity12 and the structure of the instrument has also
been investigated.11-13
The AS-20
The AS-20 is a patient-derived instrument for use in patients with a diagnosis of strabismus.
Subjects with strabismus were interviewed and statements or phrases were used to generate
a 181-item questionnaire. A number of items were subsequently removed as they were
found to be not applicable. Of the remaining items, two subscales were identified that were
applicable to the strabismic population (psychosocial and function), with each subscale
containing 10 items. A 5-point Likert type scale is applied to each question. The overall
AS-20 is given from 0 (worst HRQoL) to 100 (best HRQoL). The reliability of the AS-20,
in terms of internal consistency, and validity, in terms of discriminative validity, has been
reported.14 The instrument has also been validated in terms of concurrent validity against the
VFQ-25, and was found to be more sensitive than the NEI-VFQ-25 in detecting reduced
HRQoL in adult subjects with strabismus.15
The IXTQ
The IXTQ is a patient- and parent-derived instrument developed to measure the impact of
intermittent exotropia upon HRQoL. Children and parents of children with intermittent
exotropia were interviewed, and the results analysed to identify items and themes associated
with the diagnosis.16 Three types of questionnaire were developed: child (addressing the
child's QoL), proxy (parallel to the child questionnaire addressing parent's perception of the
child's HRQoL) and parent (addressing the parent's own HRQoL). The child questionnaire
was developed in two formats: 5–7 year olds, with a 3-point Likert-type scale; and 8–17
years, with a five-point Likert-type scale. The final child (both versions) and proxy
questionnaires contain 12 items. The parent questionnaire consists of three subscales:
function (eight items), psychosocial (seven items) and surgery (two items). The parent
instrument is also measured on a 5-point Likert-type scale. The overall IXTQ score is
calculated as the mean of all the item scores. The IXTQ has undergone initial validation, in
terms of internal consistency reliability,17 with further validity testing planned.
Strabismus and amblyopia—should these issues be considered together in the same
measure?
The presence of strabismus can be associated with three main HRQoL issues: poor cosmetic
appearance, diplopia and loss of stereopsis. The psychosocial implications of strabismus
have been well documented.21-24 The impact of amblyopia upon a person's HRQoL has not
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been as adequately explored. It is possible that the impact upon HRQoL may be related
more to the treatment of amblyopia, rather than the condition itself. To investigate the
impact of amblyopia upon HRQoL, it would be appropriate to use the ATI; this instrument
was specifically designed to quantify the impact of amblyopia on the child and the family.
On a similar note, to investigate the impact of strabismus alone on HRQoL, the AS-20 could
be used. An argument against the A&SQ as a measure is that if decreased HRQoL was
found, could the detriment to HRQoL be attributed to amblyopia or strabismus, or indeed
both. While it may not be necessary to make such a differentiation, this disadvantage of the
A&SQ as a HRQoL measure should be acknowledged.
Practical issues
All of the measures described are short instruments and as such can be easily administered,
and can be considered as a low burden for the patient/parent (see table 2). Each instrument
involves a 5-point Likert-type scale, with a 3-point scale used for the child-respondent
version aged 5–7 years in the IXTQ measure. Only the IXTQ contains a child-respondent
version. It has been recognised that proxy reporting of HRQoL can differ from self-reported
HRQoL, particularly paediatric HRQoL.25 Parents have been shown to be more able to
judge physical HRQoL components compared with emotional or social components.26 It is
possible that the HRQoL implications of strabismus and amblyopia are different depending
upon whether the child or adult perspective is taken. Ethnic differences in the impact of
strabismus and/or amblyopia upon HRQoL have not been examined. The identified
measures did not disclose their study populations in terms of ethnicity; the country of origin
for the study is shown in table 3. While the items included in any of the developed measures
may not have differed should a racially heterogeneous group have been used, the impact of
strabismus and/or amblyopia upon different groups has not been fully investigated. Socio-
economically deprived groups or ethnic minority groups may report different HRQoL
implications of strabismus and/or amblyopia.
DISCUSSION
Within the field of treating patients with a diagnosis of amblyopia and/or strabismus, the
application of HRQoL measures is a relatively new area. However, the need for such
instruments has become recognised, with the development of four new measures over recent
years. These instruments are important in that they address the specific HRQoL issues that
patients with amblyopia and/or strabismus face, issues that would not be detectable using
generic HRQoL instruments, such as the Health Utilities Index27 (HUI) or the Euroqol
Quality of Life questionnaire28 (EQ-5D). HRQoL instruments in orthoptics (the speciality of
investigating and managing patients with binocular disorders) are likely to determine the
impact of amblyopia and/or strabismus, such as the A&SQ,7-10 ATI11-13 and AS-20.14 15
The IXTQ16 17 also addresses specific issues that patients with intermittent exotropia
experience. It is possible that other strabismic conditions have their own specific issues that
impact upon HRQoL, and to that end other condition-specific measures may be required to
be developed in the future. Further research on subgroups of patients is necessary to
determine whether this is the case.
The appropriateness of condition- or disease-specific measures in determining HRQoL is a
contentious issue. While it is acknowledged that generic measures are unlikely to be
sensitive enough to detect the implications of vision-loss, poor ocular alignment or diplopia,
the question as to which of the condition-specific measures should be taken as the ‘gold
standard’ has yet to be answered. Further studies are required to compare the
appropriateness of the AS-20, A&SQ, ATI and (if appropriate) the IXTQ against each other
and a well-validated comparator (such as the VFQ-25). Further research is also required to
investigate any differences between self-reported HRQoL and proxy-reported HRQoL in
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orthoptic patients, specifically the differences between parental and self-reported HRQoL
components. It is possible that the HRQoL implications of strabismus and/or amblyopia are
not the same for both adult and child patients. Should this be the case then amendments to
existing measures or development of new measures are necessary in order to quantify the
HRQoL implications of strabismus and/or amblyopia for children. Exploration of the impact
of ethnicity upon HRQoL in orthoptic patients is also required.
The use of HRQoL instruments need not be confined to clinical trials or research. Their
application within everyday clinical practice should also be encouraged. The information
provided from an HRQoL measure may assist in the clinical decision-making process of
which treatment to prescribe and when. All of the questionnaires described can be used
without licence, and therefore do not add any significant financial burden to the patient's
investigation, aside from the extra time taken to administer the instrument. Their inclusion in
patient investigations can be considered justified as another tool to facilitate the
implementation of evidence-based practice.
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Figure 1.
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow
diagram of study identification. *Correspondence from clinical expert as articles were in
press at time of search (n=3) and through references of identified literature (n=2).
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Table 1
Assessment of health-related quality of life (HRQoL) measures
Definition Other comments
Reliability ► Ability of a measure to
reproduce the same value on
two separate occasions when
there has been no change in
health'19
► Can be over time or between methods of administration19 may be considered in terms
of internal consistency (the extent to which all items measure the same concept) or test–
retest reliability (the extent to which the results of the instrument compare if the test is
administered to the same subject on more than one occasion when there has been no
demonstrable change of health status)
Validity ► The extent to which a
measure reflects the concept
that it is intended to measure
► May be considered in terms of content validity (‘degree to which the instrument is
reflective of aspects important to the patients and disease of interest’); construct validity
‘how well a measure correlates with other indicators of similar or related constructs’);
concurrent validity (‘the extent to which an instrument correlates to other measures of the
same or similar construct’); and discriminant validity (‘the ability to discriminate between
either cases versus controls or disease severity groups’)20
► Factor analysis is a method of determining the structure of an instrument in terms of
domains or subscales. It can be used to identify redundant or duplicate items. It may also
be used to determine domain structure. Some papers refer to this as a measure of internal
validity
Responsiveness ► The extent to which the
instrument can detect in
patients known to have a
change in their physical
condition
Br J Ophthalmol. Author manuscript; available in PMC 2011 September 01.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Carlton and Kaltenthaler Page 10
Ta
bl
e 
2
Su
m
m
ar
y 
of
 h
ea
lth
-re
la
te
d 
qu
al
ity
 o
f l
ife
 (H
RQ
oL
) o
rth
op
tic
-sp
ec
ifi
c i
ns
tru
me
nts
In
st
ru
m
en
t
It
em
 p
oo
l
de
ve
lo
pm
en
t
N
um
be
r o
f q
ue
st
io
ns
Li
ke
rt
-ty
pe
 sc
al
e 
us
ed
D
om
ai
ns
 o
r 
su
bs
ca
le
s
(it
em
s)
M
od
e 
of
 a
dm
in
ist
ra
tio
n
Ps
yc
ho
m
et
ri
cs
A
&
SQ
CB
26
5-
po
in
t
Fe
ar
 o
f l
os
in
g 
be
tte
r e
ye
 (2
)
D
ist
an
ce
 e
sti
m
at
io
n 
(10
)
V
isu
al
 d
iso
rie
nt
at
io
n 
(3)
D
ip
lo
pi
a 
(4)
Pr
ob
le
m
s w
ith
 so
ci
al
 c
on
ta
ct
an
d 
co
sm
et
ic
 p
ro
bl
em
s (
4)
Se
lf
IC
, D
V
, C
V
, C
CV
A
TI
CB
, L
B
18
 (a
tro
pin
e) 
19
 (p
atc
hin
g)
5-
po
in
t 5
-p
oi
nt
A
dv
er
se
 e
ffe
ct
s (
8)
Co
m
pl
ia
nc
e 
(5)
So
ci
al
 st
ig
m
a 
(3)
Pa
re
nt
IC
, C
V
A
S-
20
PB
20
5-
po
in
t
Ps
yc
ho
so
ci
al
 (1
0)
Fu
nc
tio
n 
(10
)
Se
lf
IC
, D
V
, C
CV
,
IX
TQ
PB
12
 (p
rox
y) 
17
 (p
are
nt)
12
 (c
hil
d a
ge
d 5
–7
 ye
ars
)
12
 (c
hil
d a
ge
d 8
–1
7 y
ea
rs)
5-
po
in
t 5
-p
oi
nt
3-
po
in
t
5-
po
in
t
In
 p
ar
en
t o
nl
y
Fu
nc
tio
n 
(8)
 Ps
yc
ho
so
cia
l (
7)
Su
rg
er
y 
(2)
Pa
re
nt
, p
ro
xy
 o
r c
hi
ld
D
V
, I
C,
A
&
SQ
, A
mb
lyo
pia
 an
d S
tra
bis
mu
s Q
ue
sti
on
na
ire
; A
S-
20
, A
du
lt S
tra
bis
mu
s Q
ue
sti
on
na
ire
; A
TI
, A
mb
lyo
pia
 T
rea
tm
en
t I
nd
ex
; C
B,
 cl
ini
cia
n-b
ase
d; 
CV
, c
on
str
uc
t v
ali
dit
y; 
CC
V,
 co
nc
urr
en
t v
ali
dit
y; 
DV
,
di
sc
rim
in
an
t v
al
id
ity
; I
C,
 in
te
rn
al
 c
on
sis
te
nc
y;
 IX
TQ
; I
nte
rm
itte
nt 
Ex
otr
op
ia 
Qu
est
ion
na
ire
; L
B,
 lit
era
tur
e-b
ase
d; 
PB
, p
ati
en
t-b
ase
d; 
R,
 re
sp
on
siv
en
ess
; T
RR
, te
st–
ret
est
 re
lia
bil
ity
.
Br J Ophthalmol. Author manuscript; available in PMC 2011 September 01.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Carlton and Kaltenthaler Page 11
Table 3
Summary of research results of published studies using orthoptic-specific health-related quality of life
(HRQoL) instruments
Reference Sample Description of study Results
A&SQ
Van de Graaf et al
(the Netherlands)7
n=68 current amblyopic and
strabismic patients
n=53 healthy controls
n=174 patients from historical
cohort
Clinical experts identified problems
patients with strabismus and
amblyopia experience
Complaints categorised into themes
(loss of depth perception; diplopia
and visual disorientation; appearance)
From the themes, five domains were
developed (distance estimation; visual
disorientation; fear of losing better
eye; diplopia; appearance)
Developed a 26-item questionnaire to
be completed by the patient
Tested on three groups (current
amblyopic and strabismic patients;
healthy controls; historical cohort)
Also administered 12-item SF-12 and
the VFQ-25
Average scores for SF-12, VFQ-25 and
A&SQ were: 47.16, 93.66, 95.76 for controls;
47.13, 92.40, 83.31 for historical cohort; and
45.77, 79.16, 67.52 for patients, respectively.
Cronbach's α=fear of losing better eye (0.93);
distance estimation (0.76); visual
disorientation (0.87); diplopia (0.78); social
contact and cosmetic problems (0.83)
Van de Graaf et al
(the Netherlands)9
n=174 patients from historical
cohort
Assessed clinical validity of A&SQ
by correlating domains to orthoptic
parameters of amblyopic patients
treated 30–35 years previously
Current DRT of amblyopic eye correlated to
four domains (p<0.01) (fear of losing better
eye; distance estimation; diplopia; social
contact and cosmetic problems)
Current degree of binocular vision correlated
to two domains (p<0.01) (distance estimation;
social contact and cosmetic problems)
Felius et al (USA)8 n=150 patients Administered ASQE and compared
with clinical outcomes of VA,
diplopia and asthenopia; and
disability questionnaire of six items
on specific health, daily functioning,
social interaction, concerns about the
future, self-image, and job-related
difficulties
ASQE correlated with disability questionnaire
r=−0.76, p<0.001 Cronbach's α=fear of
losing better eye (0.80); distance estimation
(0.90); visual disorientation (0.82); diplopia
(0.82); social contact and cosmetic problems
(0.92) Spearman rank correlation coefficient
of ASQE total score and level of unilateral
acuity loss (−0.23, p<0.01); diplopia
assessment (−0.29, p<0.001); and asthenopia
assessment (−0.45, p<0.001)
Van de Graaf et al
(the
Netherlands)10
n=72 current amblyopic and
strabismic patients
n=53 healthy controls
n=173 patients from historical
cohort
Used factor analysis to compare
correlations among 26-item responses
Determined that the hypothesised five
domains of the A&SQ are valid.
Report that the domain of distance estimation
ought to be separated into two domains (near
distance estimation and far distance
estimation) resulting in an instrument that
now consists of six domains
ATI
Cole et al (USA)11 n=64 parents of patients
participating in Amblyopia
Treatment Study
20-item questionnaire developed from
clinical experience and literature
evidence issued 4 weeks after
treatment started
Used factor analysis to identify three
treatment-related factors: adverse effects (five
items), compliance (four items) and social
stigma (two items) Internal consistency
Cronbach's α=0.82 for adverse effects; 0.81
for compliance; 0.84 for social stigma
Pediatric Eye
Disease
Investigator Group
(PEDIG) (USA)12
n=364 parents of patients
participating in Amblyopia
Treatment Study
18-item questionnaire issued 5 weeks
after treatment started
Overall internal consistency
Cronbach's α=0.89
Used factor analysis to identify three
treatment-related factors: adverse effects
(eight items), compliance (five items) and
social stigma (three items)
Internal consistency Cronbach's α=0.86 for
adverse effects; 0.86 for compliance; 0.75 for
social stigma
Holmes et al
(USA)13
n=794 parents of patients
participating in Amblyopia
Treatment Study
18-item questionnaire issued 5 weeks
after treatment started
Overall internal consistency Cronbach's
α=0.88
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Used factor analysis to identify three
treatment-related factors: adverse effects
(eight items), compliance (five items) and
social stigma (three items)
Internal consistency Cronbach's α=0.85 for
adverse effects; 0.85 for compliance; 0.71 for
social stigma
AS-20
Hatt et al (USA)14 First phase n=29 strabismic
patients
Second phase n=32
strabismic patients,
n=13 controls,
n=18 other eye conditions
First phase 181-item questionnaire
issued.
Subsequent removal of 132 items
leaving 49 items for factor analysis
Final questionnaire (20-items) issued
in second phase, containing two
domains (psychosocial and function)
Overall Cronbach's α=0.94 (psychosocial
0.95, function 0.94)
Significantly lower scores for strabismus
patients (56) compared with controls (98;
p<0.001) and patients with other eye
conditions (88, p<0.001)
Hatt et al (USA)15 n=84 strabismic patients Completed AS-20 and VFQ-25Compared results with normal
VFQ-25 data and normal AS-20 data
Strabismic patients scored below normal on
AS-20 than VFQ-25 (90% cf 29%,
p<0.0001).
AS-20 detected subnormal HRQoL more than
the VFQ-25 in subjects both with and without
diplopia
IXTQ
Hatt et al (USA)17 n=33 patients n=49 controls Two child versions developed (5–7
yrs and 8–17 yrs); proxy version and
parent version
Questionnaires issued to patient and
control groups
Child questionnaire Cronbach's α=0.93
Proxy questionnaire Cronbach's α=0.97
Parent questionnaire overall Cronbach's
α=0.92 (psychosocial=0.94, function=0.94,
surgery=0.91)
A&SQ, Amblyopia and Strabismus Questionnaire; AS-20, Adult Strabismus Questionnaire; ASQE, English version of the Amblyopia and
Strabismus Questionnaire; ATI, Amblyopia Treatment Index; DRT, Dutch reading test; IXTQ, Intermittent Exotropia Questionnaire; SF-12, 12-
item Short Form; VA, visual acuity; VFQ-25, 25-item Visual Function Questionnaire.
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